Rasph

Demeta Since the EIC Accelerator: Liquidated, Resin Sold to Vipo

October 7, 20262,101 words11 min

Demeta, a green chemistry company on the Rennes Biopôle, made a resin from dicyclopentadiene (DCPD), a by-product of oil refining, using catalysts it had patented. The European Commission picked it in the 9 October 2019 cut-off of the EIC Accelerator pilot, with blended finance, for a project called i-CARE; the list names Demeta as the project's only company. CORDIS records a grant of €2,436,262.50 towards a total cost of €3,480,375, from 1 April 2020 to 30 September 2022, to qualify its NexTene™ resins for offshore energy equipment and reach "TRL9 before 2022", according to the CORDIS fact sheet. In May 2021 the company announced a €2.4 million equity agreement with the EIC Fund, according to its press release.

On 28 September 2022, two days before the project ended, the commercial court in Rennes opened receivership proceedings and fixed 12 September 2022 as the date Demeta stopped paying its debts, according to the official gazette BODACC. In January 2023 the court sold the NexTene business to the Norwegian rubber and polymer maker Vipo AS, then converted the case into liquidation. On 22 September 2025 the liquidation was closed for insufficient assets, and the company was struck off, according to BODACC and the French business register at annuaire-entreprises.

€2.44MEU grant for i-CARE
€2.4MEIC Fund convertible bonds, announced May 2021
€353kRevenue in 2021, its best year with published figures
Struck offSeptember 2025, after liquidation

Company file

Legal entity
DEMETA SAS, SIREN 531 755 346, registered in Paris in 2011 as Stratoz
Headquarters
6 rue Pierre-Joseph Colin, Rennes, from 2017
Leadership
Patrick Piot, chief executive; president: Holding Incubatrice Série II
Products
NexTene™ DCPD resins; GreenCARE bio-based specialty molecules
Investors
EIC Fund (convertible bonds, 2021); other shareholders not public
EIC project
i-CARE, EIC Accelerator pilot, October 2019 cut-off, blended finance
Staff
Not published in the register
Status
Liquidated, struck off in September 2025

What Is Left of Demeta

The company no longer exists. The register shows all four of its sites closed and the company "cessée" since 24 September 2025, two days after the liquidation was closed. Its last chief executive on file is Patrick Piot, in post since March 2017, per annuaire-entreprises; the strike-off was published in BODACC on 28 September 2025. Its former web address, demeta-solutions.com, served an online casino site when it was checked in October 2026.

The NexTene technology passed to Vipo. The court in Rennes approved on 31 January 2023 the "partial sale of the NexTene business" of Demeta to Vipo AS of Krokstadelva, Norway, with effect from 1 February 2023, and allowed a French subsidiary to take it over, according to BODACC. Vipo said it had taken over Demeta's catalysts, patents and technologies, including the NexTene family of DCPD materials, and that the Demeta brand would be dropped, according to World Pipelines. "This opens new great opportunities for unique materials in new and existing markets," Vipo's managing director Thor Hegg Eriksen said there.

The buyer's French unit did not last. Vipo France SAS was registered at Demeta's old Rennes address with Thor Hegg Eriksen as president, moved to Saint-Grégoire in 2024, transferred all its assets to Vipo AS in late 2025 and was struck off, according to BODACC notices from March 2023, December 2025 and February 2026. Vipo's website lists insulation, fire protection, piping and rubber products; it names neither NexTene nor DCPD, and its press page does not carry the Demeta acquisition. Whether Vipo still makes or sells NexTene could not be verified.

"Jugement prononçant la clôture de la procédure de liquidation judiciaire pour insuffisance d'actif."

Rennes commercial court, judgment of 22 September 2025, published in BODACC (closure of the liquidation for insufficient assets)

The Technology: A Tough Resin From a Refinery By-product

Polydicyclopentadiene (pDCPD) is a thermoset plastic made by opening the rings of DCPD molecules with a metal catalyst. It is known for being light and impact resistant. Demeta's pitch was its own patented catalysts, which it described as "molecular tools used at very low dosage", and NexTene formulations that it said matched or beat epoxy, polyurethane and polyester resins in extreme conditions with a 47% lower carbon footprint, according to CORDIS and the company's July 2021 release. The carbon figure is the company's own; no independent life-cycle study was found.

The resin was tested against real needs. Since 2018 Demeta had run a multi-year programme on deep offshore pipeline coatings and insulation under CITEPH, an industry funding scheme, with TotalEnergies, Saipem, Subsea 7, Vallourec and TechnipFMC as sponsors; the 2021 phase focused on long-term ageing, and an industrial validation phase was planned for 2022 "subject to the success of the 2021 stage", the company said. In June 2021 Vipo announced a project with Demeta, funded by the Research Council of Norway, to develop subsea thermal insulation materials using Demeta's DCPD technology, according to Vipo. That partner later became the buyer.

What the company said

A family of resins for extreme conditions, sold through a fabless model, with energy majors as customers, 27 letters of intent and full market deployment before 2022.

What the record shows

Grades launched in 2021 and first automotive sales, but revenue of €353,102 that year and receivership in September 2022.

What i-CARE Promised, and What CORDIS Shows

The objective was to take NexTene applications to technology readiness level 8 with the grant and, "thanks to the EC investors", start market deployment and reach level 9 before 2022, with production outsourced in Europe. The project's final periodic report, covering April 2021 to September 2022, lists a commercial launch of a grade for glass fibre composites in summer 2021, one grade ready for oil and gas insulation covers and two more in development, catalyst production validated at pre-commercial scale, the first industrial-scale production of NexTene, the first sales in an automotive application, ISO 45001 and ISO 9001 certification, and a technical centre "ready to start". It does not mention the receivership opened two days before the reporting period ended.

Independent sources confirm parts of this. The NexTene PCX resin for glass fibre composites was launched in October 2021, according to the company's announcement, and was shown at the CAMX trade show in 2022, according to CompositesWorld. With the German supplier H+S Automotive, Demeta developed an odourless pDCPD for car interiors; a sunroof frame made with it weighed about 900 g against 1.8 kg in steel, and prototypes went into road tests on 200 vehicles, Demeta's commercial director Ralph Hedel told Techniques de l'Ingénieur in May 2022. CompositesWorld calls the H+S partnership a joint venture; the interview describes a two-year development collaboration. No series production contract, oil and gas customer or wind energy customer was found.

  1. NexTene grade for compositesDeliveredNexTene PCX launched October 2021, shown at CAMX 2022.
  2. Oil and gas qualificationPartialOne grade ready for insulation covers per CORDIS; no oil and gas customer announced.
  3. European supply chainPartialFirst industrial-scale batch and catalyst partner, per the company's own report.
  4. Market deployment, TRL9 before 2022Not achieved€353,102 revenue in 2021; receivership in September 2022.
  5. Prototyping centre and sales teamNot achievedCentre only "ready to start" at project end; company then liquidated.

The Money

Demeta never earned much from sales. Its revenue rose from €41,850 in 2017 to €353,102 in 2021, while it lost between €682,737 and €3.1 million a year, according to ratios computed from its filed accounts and published by the French government at data.economie.gouv.fr; the 2021 revenue and loss also appear in the business register. In 2020, the first year of i-CARE, the net loss was €1,622,345. The same dataset shows the debt ratio rising from 45.7% in 2018 to 217.7% in 2021 and financial autonomy falling to 27.3%. No accounts for 2022 were filed before the receivership.

The share capital tells a similar story. Stratoz, the company's original name, was registered in Paris in April 2011 with €300,000 of capital, and raised it in steps to €8,575,464 by October 2018. In February 2019 the capital was cut to €2,594,839.20, then raised to €2,900,839.20 in January 2020, where it stayed until the company was struck off, according to the company's notices in BODACC. A cut of this kind usually absorbs past losses, but the filing does not give the reason.

The EIC Fund stake

The EIC Fund's €2.4 million came as convertible bonds "that will be redeemed in shares at the next equity fundraising", and an EIC Fund representative, Laura Vari, joined the board, Demeta said in May 2021; Techniques de l'Ingénieur also reports €4.8 million of mixed EIC funding. The registered capital did not change after January 2020, and no later equity round was found. Demeta does not appear in the EIC Fund's list of invested companies as checked across all 16 pages in October 2026. How much of the €2.4 million was paid out, and what the EIC Fund recovered in the liquidation, is not public.

Why It Mattered to Europe

Demeta's goals fitted two EU policies: the Chemicals Strategy for Sustainability, which backs safer and greener chemical processes, and the EU offshore renewable energy strategy, which needs durable materials for wind and marine equipment. A European catalyst maker for high-performance resins would also have meant less reliance on suppliers outside the EU. The outcome cuts against that: the French company was liquidated and its technology went to Norway, a country outside the EU.

The EIC Accelerator's model of a grant plus equity did not keep Demeta going after the grant ended. The grant paid for development that produced real products and test results. Sales stayed small, and the energy markets the project targeted did not turn into public customer contracts before the money ran out.

The Verdict

Products made, company lost

i-CARE delivered NexTene grades, industrial-scale batches and first automotive sales. It did not deliver the market deployment it promised: Demeta stopped paying its debts eighteen days before the project ended, sold its resin business to Vipo and was liquidated for lack of assets.

Demeta's former managers, Vipo and the EIC have not been asked for comment for this article. It is based on public records and published statements, linked throughout.

Industry

Materials and chemicalsSpecialty chemicals

Focus
  • Performance chemicals
Technologies
  • Catalysis
Keywords
  • Polydicyclopentadiene
  • Metathesis catalysts
  • Green chemistry

Start with the EIC Accelerator

Expert review for Step 1 and Step 2, suitability assessment and grant screening.

Eureka Network

Eureka Network offers multiple international collaborative R&D programs including Network Projects, Clusters, Eurostars, Globalstars, and Innowwide, with funding ranging from €50K to €6.75M per project depending on the specific program. The network focuses on market-driven innovation and deep-tech development across diverse technology sectors including ICT/Digital, Industrial/Manufacturing, Bio/Medical Technologies, Energy/Environment, Quantum, AI, and Circular Economy. Applicants include SMEs, large enterprises, research organizations, universities, and startups, with Eurostars specifically targeting R&D-performing SMEs.

EIC Transition

EIC Transition provides up to €2.5 million in funding to bridge the 'valley of death' between laboratory research and market deployment, focusing on technology maturation and validation. The program supports single legal entities or small consortia of 2-5 partners including SMEs, start-ups, spin-offs, and research organizations. Technology areas include Health/Medical Technologies, Green/Environmental Innovation, Digital/Microelectronics, Quantum Technologies, and AI/Robotics.

EIC STEP Scale-Up

EIC STEP Scale-Up offers substantial equity investments of €10-30 million for established deep-tech companies ready for hyper-growth and large-scale expansion. The program targets SMEs or small mid-caps with up to 499 employees who have secured pre-commitment from qualified investors. Focus areas include Digital & Deep Tech (Semiconductors, AI, Quantum), Clean Technologies for Net-Zero goals, and Biotechnologies.

EIC Pre-Accelerator

EIC Pre-Accelerator is a pilot program providing €300,000-€500,000 in funding for early-stage deep-tech development and preparation for the EIC Accelerator program. The initiative is exclusively available to single SMEs or small mid-caps from 'Widening countries' to support regional innovation development. The program covers deep-tech innovations across physical, biological, and digital domains.

EIC Advanced Innovation Challenges

EIC Advanced Innovation Challenges is a new pilot program offering €300,000 (Stage 1) and up to €2.5 million (Stage 2) for breakthrough deep-tech solutions through ARPA-style staged funding with demand-side integration. The program targets single entities or small consortia (2-3 partners) including SMEs, start-ups, and research organizations. Focus areas include Physical AI for autonomous robotics and New Approach Methodologies (NAMs) for animal-free biomedical testing, requiring TRL 4 entry with end-user commitment.

EIC Pathfinder

EIC Pathfinder offers up to €3 million for Open calls and up to €4 million for Challenge-based calls to support early-stage research and development with proof-of-principle validation. The program requires research consortia with a minimum of 3 partners from 3 different countries, including universities, research organizations, and SMEs. Technology focus areas include Health/Medical, Quantum Technologies, AI, Environmental/Energy, and Advanced Materials.

EIC Accelerator

EIC Accelerator provides flexible funding options including blended finance (€2.5M grant + €0.5M-€10M equity), grant-only (up to €2.5M), or equity-only arrangements for scale-up and market deployment of breakthrough innovations. The program targets SMEs, start-ups, and small mid-caps with up to 499 employees, with MedTech/Healthcare representing 35% of funded projects. Other technology areas include Biopharma, Energy, AI, Quantum, Aerospace, Advanced Materials, and Semiconductors.

Innovation Partnership

Innovation Partnership facilitates collaborative innovation between public and private sectors with typical funding of €1-5 million per project. The program supports cross-sectoral strategic technologies through public-private partnerships and consortia. Projects focus on addressing societal challenges through collaborative innovation approaches.

Innovation Fund

The EU Innovation Fund provides substantial funding of €7.5 million to €300 million for large-scale demonstration of innovative low-carbon technologies. The program targets clean energy, carbon capture, renewable energy, and energy storage technologies to accelerate the transition to a low-carbon economy. Applicants include large companies, consortia, and public entities capable of implementing large-scale demonstration projects.

Innovate UK

Innovate UK offers various programs with funding ranging from £25K to £10M depending on the specific initiative, supporting business-led innovation, collaborative R&D, and knowledge transfer. The organization funds projects across all sectors with particular focus on emerging technologies and supports UK-based businesses, research organizations, and universities. Programs are designed to drive economic growth through innovation and technology commercialization.

Industrial Partnership

Industrial Partnership provides €2-10 million in funding for industrial research and innovation partnerships focusing on manufacturing, industrial technologies, and digital transformation. The program supports industrial consortia and research organizations in developing collaborative solutions for industrial challenges. Projects aim to strengthen European industrial competitiveness through strategic partnerships.

Eurostars

Eurostars is a joint EU-Eureka program offering €50K-€500K for international R&D collaboration specifically led by SMEs. The program takes a bottom-up approach, accepting projects from all technology fields without predefined thematic restrictions. R&D-performing SMEs must lead the consortium and demonstrate significant R&D activities.

LIFE Programme

The LIFE Programme provides €1-10 million in funding for environmental protection, climate action, and nature conservation projects across the European Union. The program supports environmental technologies, climate adaptation strategies, and biodiversity conservation initiatives. Applicants include public authorities, private companies, NGOs, and research institutions working on environmental and climate challenges.

Neotec

Neotec is a Spanish program offering €250K-€1M in funding for technology-based business creation and development, supporting the growth of innovative Spanish SMEs and start-ups. The program covers all technology sectors and aims to strengthen Spain's technology ecosystem. Funding is specifically targeted at Spanish technology-based SMEs and start-ups to enhance their competitiveness and market presence.

Thematic Priorities

EU Thematic Priorities encompass various programs aligned with EU strategic priorities including green transition, digital transformation, health, and security initiatives. Funding amounts vary based on the specific program and call requirements, with projects designed to address key European challenges. Applicant eligibility varies by specific program and call, with different requirements for different thematic areas.
EIC AcceleratorBeneficiary Deep Dive#Demeta#i-CARE#NexTene#polydicyclopentadiene#green chemistry#composites#EIC Fund#Vipo#liquidation#France
Loading